New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
08:10 EDTGTIV, KNDKindred Healthcare calls on Gentiva board to negotiate transaction
Kindred Healthcare (KND) responded to the decision by the board of directors of Gentiva Health Services (GTIV) recommending against Kindred’s offer to acquire all of Gentiva’s outstanding common stock for $14.50 per share in cash. Kindred CEO Paul Diaz said, “After reviewing Gentiva’s recommendation, it remains clear that Kindred’s offer would create immediate, certain and superior value for Gentiva shareholders. We call on the Gentiva board and management team to sit down and negotiate a transaction that would advance the interests of both companies’ shareholders, employees and patients, as well as our country’s healthcare delivery system. We also call on Gentiva shareholders to make their voices heard by tendering their shares in support of Kindred’s value enhancing offer.” If a majority of the outstanding Gentiva shares are tendered prior to July 16, 2014, Kindred intends to amend the offer to seek to purchase 14.9% of Gentiva’s outstanding shares, positioning Kindred as Gentiva’s largest shareholder, the company said.
News For KND;GTIV From The Last 14 Days
Check below for free stories on KND;GTIV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 13, 2014
18:55 EDTKNDOn The Fly: After Hours Movers
UP AFTER EARNINGS: Aspen Technology (AZPN), up almost 3% after reporting better than expected Q4 results and giving Q1 and FY15 guidance on its earnings conference call. ALSO HIGHER: Kindred Healthcare (KND), up more than 1% after Point72 reported a 5.1% passive stake in the company. DOWN AFTER EARNINGS: Cisco Systems (CSCO), down 1.2% after reporting Q4 results, giving Q1 guidance, and announcing that it is cutting 8% of its workforce... Noodles & Company (NDLS), down 21.2% after reporting Q2 results and "tempering" its FY14 outlook... Conatus Pharmaceuticals (CNAT), down 13.6% after reporting Q2 results and announcing it is deferring the results of its NAFLD/NASH clinical trial to 1Q15. ALSO LOWER: Amgen (AMGN), down 2.15% after announcing the Phase 3 Kyprolis FOCUS clinical trial did not meet its primary endpoint.
16:17 EDTKNDPoint72 Asset reports 5.1% passive stake in Kindred Healthcare
Subscribe for More Information
August 11, 2014
11:10 EDTGTIVGentiva Health discloses CID from DoJ in 10-Q
Subscribe for More Information
06:57 EDTKNDAvondale to hold a conference
Subscribe for More Information
August 6, 2014
18:34 EDTKNDKindred Healthcare sees Q3 cont. ops diluted EPS 5c-15c, consensus 17c
Subscribe for More Information
18:32 EDTKNDKindred Healthcare sees FY14 cont. ops diluted EPS 96c-$1.14, consensus $1.14
The company revised its operating cash flow guidance range of $245M-$275M to a revised range of $200M-$230M. The company maintained its expectation of $100M-$105M for routine capital expenditures and for timing reasons reduced its anticipated FY14 cash outflows for development of new or replacement facilities by $5M to approximately $15M-$20M. The company expects its FY14 operating cash flows in excess of routine and development capital spending to approximate $85M-$105M, which will be available to fund acquisitions, repay debt and pay dividends. Estimated dividend payments for FY14 are expected to approximate $29M, an increase of approximately $3M from the previous guidance due to the issuance of 9.7M additional common shares in the company’s recently completed equity offering.
18:27 EDTKNDKindred Healthcare Q2 hospital division admissions growth up 3.1%
The company saw Q2 hospital division revenue growth per patient day of 1.8% and 1.3% growth in core operating costs per patient day. RehabCare division achieved sequential core operating income growth and margin improvement from 11.6% in Q1 to 12.3% in Q2. Nursing center division core operating income increased 11.3% primarily due to growth in revenues and operating margins were significantly improved due to ongoing repositioning and cost control initiatives. Care Management division delivered 66% revenue growth and core operating income doubled compared to the same period last year.
18:23 EDTKNDKindred Healthcare reports Q2 diluted continued ops EPS 34c, consensus 32c
Reports Q2 revenue $1.28B, consensus $1.28B. Q2 operating results included pretax charges of $70.9M, or 83c per diluted share related to debt refinancing, restructuring, litigation and transaction costs. Without these items, diluted earnings per share from continuing operations increased 26%.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use